NCT06405594 Neurocognitive Mechanisms of Sentence Production Impairment in Aphasia
| NCT ID | NCT06405594 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Maryland, College Park |
| Condition | Aphasia, Acquired |
| Study Type | INTERVENTIONAL |
| Enrollment | 350 participants |
| Start Date | 2024-08-01 |
| Primary Completion | 2028-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 350 participants in total. It began in 2024-08-01 with a primary completion date of 2028-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The proposed research is relevant to public health because stroke is a leading cause of long-term disability among older adults and communication impairments resulting from stroke have a significant negative impact on quality of life. By seeking to better understand post-stroke aphasia, this project lays the groundwork for development of new interventions, and aligns with NIDCD's priority areas 1 (understanding normal function), 2 (understanding diseases), and 3 (improving diagnosis, treatment, and prevention).
Eligibility Criteria
Inclusion Criteria: * At least 18 years of age * Persons with acquired aphasia are defined as those with a language impairment following left hemisphere brain injury (most likely a stroke). * Neurotypical adults need to be either young (ages 18-30 years) or older (\> 60 years) * Native (or primary) speakers of English Exclusion Criteria: * Prior neurological or psychiatric diagnoses or developmental disabilities before the onset of aphasia * do not speak English fluently
Contact & Investigator
Yasmeen Faroqi-Shah, PhD
PRINCIPAL INVESTIGATOR
University of Maryland
Frequently Asked Questions
Who can join the NCT06405594 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Aphasia, Acquired. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06405594 currently recruiting?
Yes, NCT06405594 is actively recruiting participants. Contact the research team at yfshah@umd.edu for enrollment information.
Where is the NCT06405594 trial being conducted?
This trial is being conducted at College Park, United States.
Who is sponsoring the NCT06405594 clinical trial?
NCT06405594 is sponsored by University of Maryland, College Park. The principal investigator is Yasmeen Faroqi-Shah, PhD at University of Maryland. The trial plans to enroll 350 participants.